@article{TLCR546,
author = {Alan P Skarbnik and Anthony J Olszanski},
title = {Does the order of factors affect the product? Lessons learned from the TORCH trial},
journal = {Translational Lung Cancer Research},
volume = {2},
number = {1},
year = {2012},
keywords = {},
abstract = {Lung cancer is the leading cause of cancer-related deaths globally, with a low 5-year survival rate [approximately 15 percent - NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). non-small cell lung cancer. National Comprehensive Cancer, Network 2012]. Non-small cell lung cancer (NSCLC) is the most common subtype. Traditionally, platinum-based chemotherapy has been the main frontline treatment modality for advanced NSCLC (1). Despite the many active combination chemotherapy regimens, median overall survival (OS) for advanced NSCLC remains 10-12 months.},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/546}
}